Accession Number: | 0001209191-21-007377 |
Date: | 2021-02-02 |
Issuer: | ACLARIS THERAPEUTICS, INC. (ACRS) |
Original Submission Date: |
MEHRA ANAND
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE, PA 19087
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-02-02 | M | 8,000 | a | $18.35 | 24,209 | direct | ||
COMMON STOCK | 2021-02-02 | M | 6,632 | a | $18.32 | 30,841 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION GRANT (RIGHT TO BUY) | 18.35 | 2021-02-02 | deemed execution date | M | 8,000 (d) | 2028-06-06 | common stock 8,000 | $18.35 | 0 | direct | ||
OPTION GRANT (RIGHT TO BUY) | 18.32 | 2021-02-02 | deemed execution date | M | 6,632 (d) | 2026-06-28 | common stock 6,632 | $18.32 | 0 | direct |
ID | footnote |
---|---|
f1 | the shares underlying this option vest in twelve equal monthly installments through june 7, 2019, subject to the reporting person's continuous service as of such vesting date. |
f2 | the shares underlying this option vest in twelve equal monthly installments through june 29, 2017, subject to the reporting person's continuous service as of such vesting date. |